The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase III study of trabectedin (T) or dacarbazine (D) for the treatment of patients (pts) with advanced liposarcoma (LPS) or leiomyosarcoma (LMS).
 
George D. Demetri
Consulting or Advisory Role - Bayer; EMD Serono; GlaxoSmithKline; Janssen Research & Development; Sanofi
Research Funding - Janssen Research & Development (Inst)
Expert Testimony - Janssen Research & Development
 
Margaret von Mehren
Consulting or Advisory Role - Janssen Research & Development
 
Robin Lewis Jones
Honoraria - Compass Oncology; EMD Serono; IMS Health; Novartis; Pfizer; The Dominion Group
Consulting or Advisory Role - Compass Oncology; EMD Serono; IMS Health; Novartis; Pfizer; The Dominion Group
Research Funding - Bayer (Inst); Eisai (Inst); GlaxoSmithKline (Inst); ImClone Systems (Inst); Infinity Pharmaceuticals (Inst); Janssen Research & Development (Inst); MabVax (Inst); Merck Sharp & Dohme (Inst); Morphotek (Inst); Novartis (Inst); PharmaMar (Inst); Threshold Pharmaceuticals (Inst); Ziopharm Oncology (Inst)
Travel, Accommodations, Expenses - Compass Oncology; EMD Serono; Novartis; Pfizer
 
Martee Leigh Hensley
Employment - Sanofi (I)
Consulting or Advisory Role - EMD Serono; Insys Therapeutics
Research Funding - Johnson & Johnson (Inst)
Patents, Royalties, Other Intellectual Property - author, Up to Date
 
Scott Schuetze
Research Funding - Janssen Research & Development (Inst)
 
Arthur P. Staddon
Research Funding - Janssen Research & Development (Inst)
 
Mohammed M. Milhem
No Relationships to Disclose
 
Anthony D. Elias
Consulting or Advisory Role - Genentech
Research Funding - Astellas Pharma (Inst); Genentech (Inst); Medivation (Inst)
 
Kristen N. Ganjoo
No Relationships to Disclose
 
Hussein Abdul-Hassan Tawbi
Research Funding - Janssen Research & Development (Inst)
 
Brian Andrew Van Tine
Honoraria - DFINE; EMD Serono; GlaxoSmithKline; Janssen Research & Development; Lilly; Novartis; ZIOPHARM Oncology
Speakers' Bureau - Caris Life Sciences; DFINE; GlaxoSmithKline
Research Funding - Polaris
Expert Testimony - AB Science
 
Alexander I. Spira
No Relationships to Disclose
 
Andrew Peter Dean
Honoraria - Gilead Sciences; Specialised Therapeutics
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Novartis
 
Nushmia Z. Khokhar
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Youn Choi Park
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Roland Elmar Knoblauch
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Trilok V. Parekh
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Robert G. Maki
Stock and Other Ownership Interests - Agios; Celgene; Epizyme; Gilead Sciences; Karyopharm Therapeutics
Consulting or Advisory Role - Arcus Ventures; Bayer; Eisai; Gem Pharmaceuticals; GlaxoSmithKline; Lilly/ImClone; SARC: Sarcoma Alliance for Research though Collaboration; TRACON Pharma
Research Funding - Eisai (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Uptodate: I write and edit chapters for their online text book.
Travel, Accommodations, Expenses - Bayer/Onyx; Janssen Oncology
 
Shreyaskumar Patel
Consulting or Advisory Role - CytRx Corporation; Janssen Research & Development; Novartis
Research Funding - Eisai; Janssen Research & Development; Morphotek